Because the clinical research industry is always changing, trial sponsors and research sites may feel pressured to speed up and grow their trials without sacrificing the quality of the data. This is where modern technology comes in. For DCTs to advance, both patients and clinician-researchers must accept and embrace them. Clinician-researchers and patient advocacy groups know that traditional clinical trials have accidentally left out patients from different social, economic, and cultural groups. The start of the pandemic changed how people in the industry, researchers, and patients thought about taking part in clinical trials. Thus the need for clinical development consulting. The role of digital therapeutics in supporting DCTs and healthcare is getting more support from clinicians and acceptance from patients.

How can sites deliver better data faster by connecting their eClinical technology systems with many stakeholders?

Expansion of study area

With the use of regulatory technology, research institutions can open up new locations for their studies, both locally and internationally, without having to hire more researchers. This has resulted in the widespread adoption of at-home clinical trials as a means of ensuring the successful conclusion of trials. This has also allowed sites to adopt a system that accelerates site activation, the study of startups, and the overall regulatory process.

Revenue from increased study capacity

Even though the number of clinical studies being done is growing, many centers are having trouble adding more studies. Printing, scanning, filing, keeping track of dates, managing project milestones, and other manual operations use up valuable time and resources. Since fewer tasks need to be completed on paper, many organizations have done away with binder storage areas. In many cases, this newly available space is put to better use by being turned into patient rooms, extra space for teams to work together on important tasks, or storage for the specialized scientific and medical equipment needed for precision medicine research. Research automation allows a research center that is now handling 50 studies to take on six more projects with the same amount of personnel.

Cost reduction during remote monitoring

When digital regulatory solutions and their sources are made available through a regulatory tool, there is no need to spend any time getting ready for a remote monitoring visit. To see if a tool is worth it for your team, you can input site-specific numbers and get an instant result.

Streamlined workflows reduce costs.

Document management workflows are the backbone of any successful clinical trial. Document review and signature processes for financial disclosure, protocols, training and significant adverse events take up a lot of time from research staff. They have to do things like route, annotate, fill out forms, and sign documents. Secondary tasks in the workflows, like scanning and printing the same documents over and over again and filing similar documents from study to study, create more waste. A regulatory workflow can free up coordinators and researchers from tedious administrative tasks. Electronic systems make managing clinical trials better by reducing document mistakes, making sure everything is the same, and giving more oversight to the process.

This information is important for figuring out how much to spend on a regulatory system in the future, but many of its benefits don’t fit into a standard ROI model. Each research site has its own set of qualitative indicators of value, but all of them are important, especially when you look at your investment over time.